Thromboxane biosynthesis and platelet function in type II diabetes mellitus.
暂无分享,去创建一个
[1] D. Lipkin,et al. Dissociation of Platelet Activation and Spontaneous Myocardial Ischemia in Unstable Angina , 1990, Thrombosis and Haemostasis.
[2] G. Davı̀,et al. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. , 1989, Biochimica et biophysica acta.
[3] S. Feman,et al. Thromboxane biosynthesis and platelet function in type I diabetes mellitus. , 1988, The New England journal of medicine.
[4] G. FitzGerald,et al. Paired analysis of urinary thromboxane B2 metabolites in humans. , 1987, Thrombosis research.
[5] G. FitzGerald,et al. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. , 1987, Biochimica et biophysica acta.
[6] L Roy,et al. Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.
[7] G. FitzGerald,et al. Estimated rate of thromboxane secretion into the circulation of normal humans. , 1986, The Journal of clinical investigation.
[8] R. Mayfield,et al. Platelet Function During Continuous Insulin Infusion Treatment in Insulin-dependent Diabetic Patients , 1985, Diabetes.
[9] G. Remuzzi,et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. , 1985, The Journal of clinical investigation.
[10] P. Halushka,et al. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. , 1983, The American journal of medicine.
[11] J. Witztum,et al. A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins. , 1983, The Journal of clinical investigation.
[12] G. FitzGerald,et al. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.
[13] A. le Pape,et al. Non enzymatic glycosylation increases platelet aggregating potency of collagen from placenta of diabetic human beings. , 1983, Biochemical and biophysical research communications.
[14] G. Davı̀,et al. Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics. , 1982, Thrombosis research.
[15] C. Patrono,et al. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. , 1982, The Journal of clinical investigation.
[16] A. Butkus,et al. Thromboxane production and platelet aggregation in diabetic subjects with clinical complications. , 1980, Thrombosis research.
[17] P. Majerus,et al. Inhibition of platelet prostaglandin synthetase by oral aspirin. , 1978, The Journal of clinical investigation.
[18] M. Packham,et al. Platelets and diabetes mellitus. , 1977, The New England journal of medicine.
[19] G. Born,et al. Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.
[20] S. Siegel,et al. Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.
[21] M. Mancini,et al. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. , 1985, Blood.
[22] P. Halushka,et al. Increased platelet thromboxane synthesis in diabetes mellitus. , 1981, The Journal of laboratory and clinical medicine.